NM_016239.4:c.5894G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016239.4(MYO15A):​c.5894G>A​(p.Arg1965His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00567 in 1,612,588 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1965C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0043 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 33 hom. )

Consequence

MYO15A
NM_016239.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.32

Publications

6 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008371383).
BP6
Variant 17-18142824-G-A is Benign according to our data. Variant chr17-18142824-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178445.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00432 (658/152282) while in subpopulation NFE AF = 0.00725 (493/68014). AF 95% confidence interval is 0.00672. There are 2 homozygotes in GnomAd4. There are 323 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.5894G>A p.Arg1965His missense_variant Exon 25 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.5894G>A p.Arg1965His missense_variant Exon 25 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.00432
AC:
658
AN:
152164
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00762
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00725
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00441
AC:
1077
AN:
244424
AF XY:
0.00424
show subpopulations
Gnomad AFR exome
AF:
0.00114
Gnomad AMR exome
AF:
0.00123
Gnomad ASJ exome
AF:
0.00192
Gnomad EAS exome
AF:
0.0000561
Gnomad FIN exome
AF:
0.00871
Gnomad NFE exome
AF:
0.00694
Gnomad OTH exome
AF:
0.00562
GnomAD4 exome
AF:
0.00582
AC:
8493
AN:
1460306
Hom.:
33
Cov.:
34
AF XY:
0.00575
AC XY:
4177
AN XY:
726330
show subpopulations
African (AFR)
AF:
0.00102
AC:
34
AN:
33442
American (AMR)
AF:
0.00130
AC:
58
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.00127
AC:
33
AN:
26040
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39664
South Asian (SAS)
AF:
0.000803
AC:
69
AN:
85910
European-Finnish (FIN)
AF:
0.00866
AC:
460
AN:
53122
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5764
European-Non Finnish (NFE)
AF:
0.00678
AC:
7539
AN:
1111430
Other (OTH)
AF:
0.00482
AC:
291
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
438
876
1315
1753
2191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00432
AC:
658
AN:
152282
Hom.:
2
Cov.:
32
AF XY:
0.00434
AC XY:
323
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41550
American (AMR)
AF:
0.00131
AC:
20
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4832
European-Finnish (FIN)
AF:
0.00762
AC:
81
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00725
AC:
493
AN:
68014
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00554
Hom.:
8
Bravo
AF:
0.00358
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00727
AC:
28
ESP6500AA
AF:
0.00100
AC:
4
ESP6500EA
AF:
0.00756
AC:
63
ExAC
AF:
0.00430
AC:
520
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00573
EpiControl
AF:
0.00536

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MYO15A: BP4, BS2 -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:1
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg1965His in Exon 25 of MYO15A: This variant is not expected to have clinical s ignificance because it has been identified in 0.6% (43/6736) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs139347804). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.34
T;D;D
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.73
T;.;T
MetaRNN
Benign
0.0084
T;T;T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
0.74
.;N;N
PhyloP100
2.3
PrimateAI
Benign
0.20
T
PROVEAN
Uncertain
-3.1
.;D;.
REVEL
Benign
0.26
Sift
Benign
0.15
.;T;.
Sift4G
Benign
0.42
T;T;.
Polyphen
0.010
.;B;B
Vest4
0.30
MVP
0.60
ClinPred
0.032
T
GERP RS
0.56
Varity_R
0.059
gMVP
0.57
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139347804; hg19: chr17-18046138; API